Intensive Care Medicine

Aims & Scope

The journal Intensive Care Medicine provides a medium for the communication and exchange of current work and ideas in this field.

It is intended for all involved in intensive medical care, physicians, anaesthetists, surgeons, pediatricians, and all concerned with the pre-clinical subjects and medical sciences basic to these disciplines.

It publishes - Review articles reflecting the present state of knowledge in special areas or summarizing limited Themes in which discussion has led to clearly defined conclusions - Original papers reporting progress and results in all areas of intensive care medicine and its related fields - Educational articles giving information on the progress of a topic of particular interest - Discussion on technology, methods, new apparatus and modifications of standard techniques - Correspondence concerning matters of topical interest or relating to published material - Book reviews - Reports of meetings - Announcements The journal is open for publication of supplements and for publishing abstracts of scientific meetings.

Conditions can be obtained from the Editor-in-Chief or the publisher.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	21.2
2024	27.10

SJR (SCImago Journal Rank)

Year	Value
2024	4.999

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	246

Journal Rank

Year	Value
2024	294

Journal Citation Indicator

Year	Value
2024	6088

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  Citation: 8568

  Authors: J. -L., R., J., S., A., H., C. K., P. M., L. G.

• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

  Citation: 4689

  Authors: Andrew, Laura E., Waleed, Mitchell M., Massimo, Ricard, Anand, Jonathan E., Charles L., Mark E., Bram, Gordon D., Derek C., Djillali, Richard J., Geoffrey J., Gordon R., Jean-Daniel, Craig, Daniel P., Craig J., Seitaro, Herwig, Jorge Luis, Steven M., Alan E., Dilip R., Ruth M., Younsuk, Thiago Costa, Flavia R., John J., John C., John E., Lauralyn A., Anthony S., Sangeeta, Rui P., John, Paolo, Osamu, Tiffany M., Anders, Colleen M., Marco, Christa A., Maureen A., Christopher W., Lisa, Khalid A., Steven Q., Mervyn, B. Taylor, Sean R., Thomas, Jean-Louis, W. Joost, Janice L., R. Phillip

• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  Citation: 3370

  Authors: R. P., Mitchell M., Andrew, Djillali, Herwig, Steven M., Jonathan E., Charles L., Ivor S., Roman, Tiffany M., Mark E., Sean R., Konrad, Ruth M., Derek C., Clifford S., Flavia R., Gordon D., Steven, Richard J., Jean-Louis, Rui

• Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

  Citation: 3353

  Authors: Qiurong, Kun, Wenxia, Lingyu, Jianxin

• Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

  Citation: 3050

  Authors: Laura, Andrew, Waleed, Massimo, Craig M., Craig, Flávia R., Lauralyn, Marlies, Hallie C., Christa, Steven, W. Joost, Fayez, Derek C., Yaseen, Luciano, Richard, Gregory, Emilie, Lisa, Maurizio, John, Angel, Jan, R. Phillip, Kent, Bin, Elisa, Ricard, Charles, Carol, Morten Hylander, Theodore, Shevin, Ruth, Michael, Younsuck, Anand, Arthur, Suzana, Henry, Steven, Sangeeta, Yatin, Mervyn, Mark, Simon, Tiffany, Elizabeth, Anders, Michael, Jason, William, Maureen, Jonathan, Charles L., Tobias, Janice, Mitchell

• International evidence-based recommendations for point-of-care lung ultrasound

  Citation: 2258

  Authors: Giovanni, Mahmoud, Michael, Daniel A., Gebhard, Andrew W., Lawrence, Luna, Vicki E., Gabriele, Anthony, James W., Gino, Roberto, Belaid, Angelika, Eustachio, Jean-Jacques, Charlotte, Andrew, Ashot, Fernando, Richard, Raoul, Armin, Luca, Enrico, Tomislav

• Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

  Citation: 2231

  Authors: Eric A. J., Sean M., Rinaldo, Cynthia M., Roos, Dinna N., Kyriakos, Lui G., Charles D., Deepak, Patrick M., Olivier, Michael, Anna-Maija, Athina, Ravindra L., Paul, Eric, Claudio, Shigehiko, Jorge A., Erick, Steve, John A.

• High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

  Citation: 2207

  Authors: Julie, Charles, François, Ian, Mickaël, Xavier, Hamid, Raphaël, Malika, Florence, Samira, Vincent, Francis, Lélia, Eduardo, Laurent, Paul-Michel, Ferhat

• Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

  Citation: 1990

  Authors: Haibo, Josef M., Yimin, Nanshan, Arthur S.

• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  Citation: 1845

  Authors: Mitchell M., Mitchell P., John C., Edward, Derek, Deborah, Jonathan, Steven M., Jean-Louis, Graham

---